Table of Contents

1 Study Coverage

• 1.1 Insulin Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Insulin Market Size Growth Rate by Product
  • 1.4.2 Short-acting
  • 1.4.3 Mid-acting
  • 1.4.4 Long-acting
• 1.5 Market by End User
  • 1.5.1 Global Insulin Market Size Growth Rate by End User
  • 1.5.2 Hospital
  • 1.5.3 Clinic
  • 1.5.4 Home Usage
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Insulin Market Size
  • 2.1.1 Global Insulin Revenue 2014-2025
  • 2.1.2 Global Insulin Sales 2014-2025
• 2.2 Insulin Growth Rate by Regions
  • 2.2.1 Global Insulin Sales by Regions
  • 2.2.2 Global Insulin Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Insulin Sales by Manufacturers
  • 3.1.1 Insulin Sales by Manufacturers
  • 3.1.2 Insulin Sales Market Share by Manufacturers
  • 3.1.3 Global Insulin Market Concentration Ratio (CR5 and HHI)
• 3.2 Insulin Revenue by Manufacturers
  • 3.2.1 Insulin Revenue by Manufacturers (2014-2019)
  • 3.2.2 Insulin Revenue Share by Manufacturers (2014-2019)
• 3.3 Insulin Price by Manufacturers
• 3.4 Insulin Manufacturing Base Distribution, Product Types
  • 3.4.1 Insulin Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Insulin Product Type
  • 3.4.3 Date of International Manufacturers Enter into Insulin Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Insulin Sales by Product
• 4.2 Global Insulin Revenue by Product
• 4.3 Insulin Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Insulin Breakdown Data by End User

6 North America

• 6.1 North America Insulin by Countries
  • 6.1.1 North America Insulin Sales by Countries
  • 6.1.2 North America Insulin Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Insulin by Product
• 6.3 North America Insulin by End User

7 Europe

• 7.1 Europe Insulin by Countries
  • 7.1.1 Europe Insulin Sales by Countries
  • 7.1.2 Europe Insulin Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Insulin by Product
• 7.3 Europe Insulin by End User

8 Asia Pacific

• 8.1 Asia Pacific Insulin by Countries
  • 8.1.1 Asia Pacific Insulin Sales by Countries
  • 8.1.2 Asia Pacific Insulin Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Insulin by Product
• 8.3 Asia Pacific Insulin by End User

9 Central & South America

• 9.1 Central & South America Insulin by Countries
  • 9.1.1 Central & South America Insulin Sales by Countries
  • 9.1.2 Central & South America Insulin Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Insulin by Product
• 9.3 Central & South America Insulin by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Insulin by Countries
  • 10.1.1 Middle East and Africa Insulin Sales by Countries
  • 10.1.2 Middle East and Africa Insulin Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Insulin by Product
• 10.3 Middle East and Africa Insulin by End User

11 Company Profiles

• 11.1 Novo Nordisk
  • 11.1.1 Novo Nordisk Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Novo Nordisk Insulin Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Novo Nordisk Insulin Products Offered
  • 11.1.5 Novo Nordisk Recent Development
• 11.2 Sanofi
  • 11.2.1 Sanofi Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Sanofi Insulin Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Sanofi Insulin Products Offered
  • 11.2.5 Sanofi Recent Development
• 11.3 Eli Lilly
  • 11.3.1 Eli Lilly Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Eli Lilly Insulin Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Eli Lilly Insulin Products Offered
  • 11.3.5 Eli Lilly Recent Development
• 11.4 Bioton
  • 11.4.1 Bioton Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Bioton Insulin Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Bioton Insulin Products Offered
  • 11.4.5 Bioton Recent Development
• 11.5 Dongbao
  • 11.5.1 Dongbao Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Dongbao Insulin Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Dongbao Insulin Products Offered
  • 11.5.5 Dongbao Recent Development
• 11.6 Gan & Lee
  • 11.6.1 Gan & Lee Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Gan & Lee Insulin Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Gan & Lee Insulin Products Offered
  • 11.6.5 Gan & Lee Recent Development
• 11.7 United Laboratories (TUL)
  • 11.7.1 United Laboratories (TUL) Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 United Laboratories (TUL) Insulin Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 United Laboratories (TUL) Insulin Products Offered
  • 11.7.5 United Laboratories (TUL) Recent Development

12 Future Forecast

• 12.1 Insulin Market Forecast by Regions
  • 12.1.1 Global Insulin Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Insulin Revenue Forecast by Regions 2019-2025
• 12.2 Insulin Market Forecast by Product
  • 12.2.1 Global Insulin Sales Forecast by Product 2019-2025
  • 12.2.2 Global Insulin Revenue Forecast by Product 2019-2025
• 12.3 Insulin Market Forecast by End User
• 12.4 North America Insulin Forecast
• 12.5 Europe Insulin Forecast
• 12.6 Asia Pacific Insulin Forecast
• 12.7 Central & South America Insulin Forecast
• 12.8 Middle East and Africa Insulin Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Insulin Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Insulin market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Insulin market based on company, product type, end user and key regions.

This report studies the global market size of Insulin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Insulin in these regions.
This research report categorizes the global Insulin market by top players/brands, region, type and end user. This report also studies the global Insulin market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novo Nordisk
Sanofi
Eli Lilly
Bioton
Dongbao
Gan & Lee
United Laboratories (TUL)

Market size by Product
Short-acting
Mid-acting
Long-acting
Market size by End User
Hospital
Clinic
Home Usage

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Insulin market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Insulin market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Insulin companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Insulin submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Insulin are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Insulin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.